Somatic Advantage 74 (DNA+RNA) (RAPID)

Test Code
SLS162012
Book Now

What is the Somatic Advantage 74 RAPID Test?

This is an accelerated version of the Somatic Advantage 74 test. It delivers rapid results while still evaluating 74 genes for mutations using DNA sequencing and 14 genes for fusions using RNA sequencing.

Genes Covered/ No. of Genes: 74 Genes, 14 Fusions

Who Is This Test For?

Patients with solid tumors who require rapid molecular insights to guide urgent treatment decisions, or individuals in whom treatment planning is time-sensitive, such as in aggressive or advanced-stage cancers

Key Features

  • Comprehensive analysis of 74 genes for mutations using DNA sequencing and 14 genes for fusions using RNA sequencing
  • Optimized for faster result delivery to support immediate clinical needs
  • Detects a broad range of actionable mutations, resistance markers, and driver gene fusions
  • Applicable across multiple solid tumor types

Clinical Applications

  • Enables timely selection of targeted therapies based on genomic alterations
  • Identifies resistance mechanisms to guide second-line or combination treatments
  • Supports clinical trial matching and personalized treatment strategies
  • Assists in real-time treatment decision-making for patients with limited therapeutic windows

All Solid Tumors, Comprehensive Profiling

Contact Us